Literature DB >> 24114472

Obesity, energy balance, and cancer: a mechanistic perspective.

Stephen D Hursting1.   

Abstract

Nearly 36 % of adults and 20 % of children in the USA are obese, defined as a body mass index (BMI) ≥30 kg/m(2). Obesity, which is accompanied by metabolic dysregulation often manifesting in the metabolic syndrome, is an established risk factor for many cancers. Within the growth-promoting, proinflammatory environment of the obese state, cross talk between macrophages, adipocytes, and epithelial cells occurs via obesity-associated hormones, cytokines, and other mediators that may enhance cancer risk and/or progression. This chapter synthesizes the evidence on key biological mechanisms underlying the obesity-cancer link, with particular emphasis on obesity-associated enhancements in growth factor signaling, inflammation, and vascular integrity processes, as well as obesity-dependent microenvironmental perturbations, including the epithelial-to-mesenchymal transition. These interrelated pathways represent possible mechanistic targets for disrupting the obesity-cancer link.

Entities:  

Mesh:

Year:  2014        PMID: 24114472     DOI: 10.1007/978-3-642-38007-5_2

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  27 in total

Review 1.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

2.  Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest.

Authors:  Christie A Befort; Bruce F Kimler; Leonidas E Bantis; Teresa A Phillips; Carol J Fabian
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-10       Impact factor: 4.254

3.  Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients.

Authors:  Zhi-Bin Bai; Yong-Lin Qin; Gang Deng; Guo-Feng Zhao; Bin-Yan Zhong; Gao-Jun Teng
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

4.  The influence of different calorie restriction protocols on serum pro-inflammatory cytokines, adipokines and IGF-I levels in female C57BL6 mice: short term and long term diet effects.

Authors:  Soner Dogan; Amitabha Ray; Margot P Cleary
Journal:  Meta Gene       Date:  2017-01-03

Review 5.  Can Brown Fat Win the Battle Against White Fat?

Authors:  Sawsan Elattar; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

Review 6.  Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.

Authors:  Bal Krishan Sharma; Mallikarjun Patil; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

7.  Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon.

Authors:  M Agostina Santoro; R Eric Blue; Sarah F Andres; Amanda T Mah; Laurianne Van Landeghem; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

8.  Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study.

Authors:  Maura Harrigan; Brenda Cartmel; Erikka Loftfield; Tara Sanft; Anees B Chagpar; Yang Zhou; Mary Playdon; Fangyong Li; Melinda L Irwin
Journal:  J Clin Oncol       Date:  2015-11-23       Impact factor: 44.544

Review 9.  Obesity and cancer pathogenesis.

Authors:  Nathan A Berger
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

10.  Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk.

Authors:  M Agostina Santoro; Sarah F Andres; Joseph A Galanko; Robert S Sandler; Temitope O Keku; P Kay Lund
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-13       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.